German study says regulatory reports are good sources of drug data

10/24/2013 | Reuters

A study from Germany found that seldom-released regulatory reports do a better job than publicly available documents of detailing drugs' efficacy and side effects. Lead author Beate Wieseler said the FDA and the European Medicines Agency could begin publishing these reports on their websites, but a representative of the FDA said the agency is legally bound not to release a fair amount of that data. Drugmakers are at ease sharing clinical data with certified researchers on the condition that information is used appropriately and patient privacy is protected, said Jeff Francer, the vice president and assistant general counsel for the Pharmaceutical Research and Manufacturers of America.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA